Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
PERNIX THERAPEUTICS HOLDINGS, INC. (PTX)
|
|
Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
In millions, except per share items | Sep-30-18 | Jun-30-18 | Mar-31-18 | Dec-31-17 | Sep-30-17 | Jun-30-17 | Mar-31-17 | Dec-31-16 |
| 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K |
Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
Cost of goods sold | 31.2% | 29.4% | 30.1% | 30.6% | 29.8% | 29.8% | 30.5% | 37.6% |
Gross profit | 68.8% | 70.6% | 69.9% | 69.4% | 70.2% | 70.2% | 69.5% | 62.4% |
Selling, general and administrative | 107.0% | 98.9% | 101.3% | | 150.8% | 163.8% | 168.4% | |
General and administrative | | | | 36.1% | | | | 85.0% |
EBITDA | -69.8% | -47.2% | -37.0% | -38.2% | -94.4% | -72.9% | -73.7% | -94.9% |
Depreciation | 0.3% | 0.3% | 0.3% | 0.3% | 0.3% | 0.7% | 15.8% | 39.4% |
EBITA | -70.2% | -47.5% | -37.2% | -38.4% | -94.7% | -73.5% | -89.5% | -134.3% |
Amortization of intangibles | -32.3% | -19.4% | -6.0% | 0.0% | -7.5% | 27.0% | 13.4% | 0.0% |
EBIT | -37.9% | -28.1% | -31.2% | -38.4% | -87.2% | -100.5% | -102.9% | -134.3% |
Pre-tax income | -66.8% | -44.1% | -45.6% | -52.6% | -96.7% | -120.2% | -125.0% | -146.9% |
Income taxes | 0.3% | 0.2% | 0.2% | 0.3% | 0.4% | 0.4% | 0.3% | 0.4% |
Net income | 25.7% | 38.9% | 35.3% | 34.9% | 66.7% | 42.1% | 18.8% | 0.0% |
|